National Pension Service raised its stake in shares of Boston Scientific Corporation (NYSE:BSX) by 2.7% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,205,485 shares of the medical equipment provider’s stock after purchasing an additional 31,539 shares during the period. National Pension Service’s holdings in Boston Scientific were worth $29,884,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bank of Montreal Can lifted its holdings in shares of Boston Scientific by 35.7% in the 4th quarter. Bank of Montreal Can now owns 2,767,978 shares of the medical equipment provider’s stock valued at $68,618,000 after acquiring an additional 727,508 shares during the last quarter. Vontobel Asset Management Inc. lifted its holdings in shares of Boston Scientific by 19.2% in the 4th quarter. Vontobel Asset Management Inc. now owns 1,651,580 shares of the medical equipment provider’s stock valued at $40,945,000 after acquiring an additional 266,067 shares during the last quarter. Private Trust Co. NA lifted its holdings in shares of Boston Scientific by 14.5% in the 4th quarter. Private Trust Co. NA now owns 54,642 shares of the medical equipment provider’s stock valued at $1,354,000 after acquiring an additional 6,905 shares during the last quarter. DnB Asset Management AS lifted its holdings in shares of Boston Scientific by 13.1% in the 4th quarter. DnB Asset Management AS now owns 151,150 shares of the medical equipment provider’s stock valued at $3,747,000 after acquiring an additional 17,500 shares during the last quarter. Finally, QUANTRES ASSET MANAGEMENT Ltd bought a new position in shares of Boston Scientific in the 4th quarter valued at about $647,000. 90.51% of the stock is owned by institutional investors and hedge funds.
A number of research analysts recently commented on the stock. Canaccord Genuity assumed coverage on shares of Boston Scientific in a report on Tuesday, October 24th. They issued a “buy” rating and a $36.00 price target for the company. Zacks Investment Research raised shares of Boston Scientific from a “sell” rating to a “buy” rating and set a $33.00 price target for the company in a report on Friday, October 20th. Needham & Company LLC reaffirmed a “buy” rating and issued a $32.00 price target on shares of Boston Scientific in a report on Tuesday, October 3rd. BMO Capital Markets reaffirmed a “buy” rating and issued a $30.00 price target on shares of Boston Scientific in a report on Friday, October 13th. Finally, SunTrust Banks reaffirmed a “buy” rating and issued a $34.00 price target on shares of Boston Scientific in a report on Monday, October 2nd. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Boston Scientific presently has an average rating of “Buy” and an average price target of $31.00.
Boston Scientific (NYSE:BSX) last issued its earnings results on Thursday, October 26th. The medical equipment provider reported $0.31 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.31. The business had revenue of $2.22 billion for the quarter, compared to analyst estimates of $2.21 billion. Boston Scientific had a net margin of 9.55% and a return on equity of 23.60%. The company’s quarterly revenue was up 5.6% compared to the same quarter last year. During the same period last year, the company posted $0.27 earnings per share. research analysts anticipate that Boston Scientific Corporation will post 1.25 EPS for the current year.
In related news, insider Valley Gold Master Fund L. Sun bought 408,006 shares of Boston Scientific stock in a transaction dated Tuesday, November 28th. The shares were acquired at an average cost of $0.45 per share, with a total value of $183,602.70. Also, SVP David A. Pierce sold 8,763 shares of the firm’s stock in a transaction that occurred on Thursday, January 11th. The stock was sold at an average price of $27.74, for a total transaction of $243,085.62. Following the transaction, the senior vice president now directly owns 24,201 shares in the company, valued at $671,335.74. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 96,585 shares of company stock worth $2,578,197. Corporate insiders own 0.74% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “National Pension Service Grows Holdings in Boston Scientific Corporation (BSX)” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States and international trademark & copyright laws. The legal version of this article can be read at https://www.tickerreport.com/banking-finance/3145584/national-pension-service-grows-holdings-in-boston-scientific-corporation-bsx.html.
About Boston Scientific
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology.
Want to see what other hedge funds are holding BSX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Boston Scientific Corporation (NYSE:BSX).
Receive News & Ratings for Boston Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific and related companies with MarketBeat.com's FREE daily email newsletter.